Identifying influencing factors of metabolic syndrome in patients with major depressive disorder: A real-world study with Bayesian network modeling

被引:0
作者
Qi, Han [1 ,2 ,3 ]
Liu, Rui [1 ,2 ,3 ]
Dong, Cheng-Cheng [1 ,2 ,3 ]
Zhu, Xue-Quan [1 ,2 ,3 ]
Feng, Yuan [1 ,2 ,3 ]
Wang, Hai-Ning [4 ]
Li, Lei [5 ,7 ,8 ,9 ]
Chen, Fei [6 ]
Wang, Gang [1 ,2 ,3 ]
Yan, Fang [1 ,2 ,3 ]
机构
[1] Capital Med Univ, Beijing Anding Hosp, Natl Clin Res Ctr Mental Disorders, Beijing Key Lab Mental Disorders, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Anding Hosp, Natl Ctr Mental Disorders, Beijing, Peoples R China
[3] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing 100088, Peoples R China
[4] Peking Univ Third Hosp, Dept Endocrinol & Metab Dis, Beijing, Peoples R China
[5] Peking Univ Third Hosp, Dept Cardiol, Beijing, Peoples R China
[6] Peking Univ, Peking Univ Hlth Sci Ctr, Grad Sch, Beijing, Peoples R China
[7] Peking Univ, State Key Lab Vasc Homeostasis & Remodeling, Beijing, Peoples R China
[8] Peking Univ, NHC Key Lab Cardiovasc Mol Biol & Regulatory Pepti, Beijing, Peoples R China
[9] Beijing Key Lab Cardiovasc Receptors Res, Beijing, Peoples R China
关键词
Major depressive disorder; Metabolic syndrome; Bayesian network; Real-world data; Influencing factors; MENTAL-DISORDERS; PREVALENCE; ASSOCIATION; HEALTH; RISK;
D O I
10.1016/j.jad.2024.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The bidirectional relationships between metabolic syndrome (MetS) and major depressive disorder (MDD) were discovered, but the influencing factors of the comorbidity were barely investigated. We aimed to fully explore the factors and their associations with MetS in MDD patients. Methods: The data were retrieved from the electronic medical records of a tertiary psychiatric hospital in Beijing from 2016 to 2021. The influencing factors were firstly explored by univariate analysis and multivariate logistic regressions. The propensity score matching was used to reduce the selection bias of participants. Then, the Bayesian networks (BNs) with hill-climbing algorithm and maximum likelihood estimation were preformed to explore the relationships between influencing factors with MetS in MDD patients. Results: Totally, 4126 eligible subjects were included in the data analysis. The proportion rate of MetS was 32.6 % (95 % CI: 31.2 %-34.1 %). The multivariate logistic regression suggested that recurrent depression, uric acid, duration of depression, marriage, education, number of hospitalizations were significantly associated with MetS. In the BNs, number of hospitalizations and uric acid were directly connected with MetS. Recurrent depression and family history psychiatric diseases were indirectly connected with MetS. The conditional probability of MetS in MDD patients with family history of psychiatric diseases, recurrent depression and two or more times of hospitalizations was 37.6 %. Conclusion: Using the BNs, we found that number of hospitalizations, recurrent depression and family history of psychiatric diseases contributed to the probability of MetS, which could help to make health strategies for specific MDD patients.
引用
收藏
页码:308 / 316
页数:9
相关论文
共 50 条
  • [21] Characteristics and current standard of care among veterans with major depressive disorder in the United States: A real-world data analysis
    Zhao, Xiaohui
    Karkare, Swapna
    Nash, Abigail, I
    Sheehan, John J.
    Aboumrad, Maya
    Near, Aimee M.
    Banerji, Tania
    Joshi, Kruti
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 307 : 184 - 190
  • [22] Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study
    Muraoka, Hiroyuki
    Kodaka, Fumitoshi
    Hasegawa, Naomi
    Yasui-Furukori, Norio
    Fukumoto, Kentaro
    Kashiwagi, Hiroko
    Tagata, Hiromi
    Hori, Hikaru
    Atake, Kiyokazu
    Iida, Hitoshi
    Ichihashi, Kayo
    Furihata, Ryuji
    Tsuboi, Takashi
    Takeshima, Masahiro
    Komatsu, Hiroshi
    Kubota, Chika
    Ochi, Shinichiro
    Takaesu, Yoshikazu
    Usami, Masahide
    Nagasawa, Tatsuya
    Makinodan, Manabu
    Nakamura, Toshinori
    Kido, Mikio
    Ueda, Ikki
    Yamagata, Hirotaka
    Onitsuka, Toshiaki
    Asami, Takeshi
    Hishimoto, Akitoyo
    Ogasawara, Kazuyoshi
    Katsumoto, Eiichi
    Miura, Kenichiro
    Matsumoto, Junya
    Ohi, Kazutaka
    Yamada, Hisashi
    Watanabe, Koichiro
    Inada, Ken
    Nishimura, Katsuji
    Hashimoto, Ryota
    ASIAN JOURNAL OF PSYCHIATRY, 2022, 74
  • [23] Peripheral biomarkers to differentiate bipolar depression from major depressive disorder: a real-world retrospective study
    Lyu, Nan
    Wang, Han
    Zhao, Qian
    Fu, Bingbing
    Li, Jinhong
    Yue, Ziqi
    Huang, Juan
    Yang, Fan
    Liu, Hao
    Zhang, Ling
    Li, Rena
    BMC PSYCHIATRY, 2024, 24 (01)
  • [24] Prevalence of Metabolic Syndrome among Patients with Major Depressive Disorder - Differences Between Newly Diagnosed First Episode and Recurrent Disease
    Ljubicic, Rudolf
    Jakovac, Hrvoje
    Bistrovic, Ivana Ljubicic
    Franceski, Tanja
    Mufic, Ana Kovak
    Karlovic, Dalibor
    COLLEGIUM ANTROPOLOGICUM, 2013, 37 (04) : 1065 - 1069
  • [25] Association of paraoxonase-1 activity and major depressive disorder in patients with metabolic syndrome
    Ari, Hatem
    Kayrak, Mehmet
    Gunduz, Mehmet
    Kayhan, Fatih
    Kaya, Zeynettin
    Kiyici, Aysel
    Uguz, Faruk
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2015, 35 : S258 - S263
  • [26] Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study
    Roger S. McIntyre
    Emmanuelle Weiller
    Advances in Therapy, 2015, 32 : 429 - 444
  • [27] Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study
    McIntyre, Roger S.
    Weiller, Emmanuelle
    ADVANCES IN THERAPY, 2015, 32 (05) : 429 - 444
  • [28] Identifying the nature of episodic memory deficits in Major Depressive Disorder using a Real-World What-Where-When task
    Foka, Kyriaki
    Hunt, Hannah
    Constantinescu, Simona
    Choudhury, Tahsina
    Walker, Thomas J.
    Black-Dominique, Amber
    Lai, Daniel
    Bhoopathy, Raja
    Sanderson, Olivia
    Wray, Lauren
    McAllister-Williams, R. Hamish
    Gallagher, Peter
    Smulders, Tom V.
    MEMORY, 2024, 32 (07) : 924 - 934
  • [29] A comparison of real-world effectiveness of vortioxetine along the treatment algorithm for major depressive disorder
    Bose, Rohini
    Hamdani, Syed Usman
    Minhas, Fareed Aslam
    Herr, Keira Joann
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (05) : 661 - 671
  • [30] Prevalence and risk factors of anxiety symptoms in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome
    Liu, Jizhou
    Yang, Yonglan
    Zhang, Yanjiang
    Wang, Haifeng
    Wei, Wenjian
    Lang, Xiaoe
    Zhang, Xiangyang
    EUROPEAN JOURNAL OF PSYCHIATRY, 2023, 37 (04)